Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
143 hedge funds and large institutions have $260M invested in Vaxart in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 31 reducing their positions, and 35 closing their positions.
90% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 31
33% more capital invested
Capital invested by funds: $195M → $260M (+$65.1M)
11% more call options, than puts
Call options by funds: $27.4M | Put options by funds: $24.7M
1.07% more ownership
Funds ownership: 27.38% → 28.45% (+1.1%)
10% less funds holding
Funds holding: 159 → 143 (-16)
43% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$19.2M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.12M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$3.44M |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
+$3.21M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$7.33M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
-$5.25M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.48M |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$3.39M |
| 5 |
Rafferty Asset Management
New York
|
-$1.37M |
VXRT Hedge Fund Activity: Q2 2021 in Review
143 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2021, worth a combined $260M — up 33% from $195M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of VXRT and 20 opened new positions — a net loss of 15 holders — while 31 trimmed existing stakes and 59 added.
The largest buyer was BlackRock, adding an estimated $19.2M. The largest seller was State Street, cutting an estimated $7.33M.
- 143 institutional investors held Vaxart (VXRT) as of Q2 2021, down from 159 in Q1 2021.
- Funds reported $260M of Vaxart stock for Q2 2021, up 33% quarter-over-quarter.
- 20 funds opened new Vaxart positions in Q2 2021 and 35 closed out, a net change of -15 holders.
- The largest Vaxart buyer in Q2 2021 was BlackRock, an estimated $19.2M added.
- The largest Vaxart seller in Q2 2021 was State Street, an estimated $7.33M sold.
Based on aggregated 13F filings for Q2 2021.